Tag Archives: Technology Transfer

Technology Transfer: Promoting Public-Private Collaborations for Innovation

Jim Greenwood

BIO President and CEO Jim Greenwood penned an op-ed for the September issue of BioPharm International on the importance of technology transfer from academia to industry, as encouraged by the Bayh-Dole Act of 1980. The Bayh-Dole Act, which permits and encourages industry to partner with research universities to turn federally-funded basic research into new and valuable products, is a critical factor in driving America’s innovation economy. Because of this legislation, the U.S. leads the world Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , ,

Finding Value in Early Stage Collaborations at the BIO Technology Transfer Symposium

Bridge

The BIO Technology Transfer Symposium dissects recent academia-industry collaborations and evaluates the value in early stage biotechnology investments.  The event occurs in San Francisco on October 8th ahead of the BIO Investor Forum and provides a unique opportunity for bringing academia, industry, and the investment community together. This year’s event is headlined by Tom Thornton from the Cleveland Clinic, a leading academic medical center.  The first panel highlights the collaboration between Duke Translational Research Institute Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,

Preview: AUTM U.S. Licensing Survey: FY2011

044-btn

We’ve seen compelling evidence recently about the positive impact of university licensing activity. As we learned from “The Economic Contributions of University/Nonprofit Inventions in the United States: 1996-2010,” a report released by BIO in June, university/nonprofit licensing supported as many as 3 million “person years of employment.” Now there is even more good news to share. AUTM publishes a report of academic licensing activity at the end of each year for the prior fiscal year. Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,

Spotlight on India’s Emerging Biotech Sector

india-flag

India’s biotechnology sector is a burgeoning one, with more than 325 companies and some with revenues in the billions of dollars. According to the BioSpectrum-ABLE (Association of Biotechnology Led Enterprises) Biotech Industry Survey of 2011, the industry has grown by 21.5% in 2006-2011, surging to $4 billion. Furthermore, India is the world’s largest manufacturer of vaccines and the growth of India vaccine makers arises from their ability to develop and produce high-quality vaccines with low Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Technology Transfer Impact? Senator Bayh Informs on IPWatchdog

BirchBayh

IPWatchdog published an article by former Senator Birch Bayh highlighting a BIO commissioned study showing the economic impact of technology transfer on the U.S. economy.  “A new study shows that this spinning of straw into gold is precisely what our academic research organizations have been quietly doing year after year.  The just released report “The Economic Contribution of University/Nonprofit Inventions in the United States: 1996-2010” provides a much needed dose of good economic news when Read More >

Patently BIOtech  |  3 Comments  |  Email This Post
Tags: ,